Major Japanese newspaper reports iPS cells already transplanted into human patients at Harvard - The Niche
How concerned I was that iPS cells might be used in early phase human trials and that would be high risk given safety concerns about iPS cells.
Professor Paul Knoepfler, Ph.D.
